1.

(
)Result from participation in health behavior modification in
population at risk for cardiovascular disease
2.

. .

3.

(Rationale)

. . 2550-25594

4.

pedometer
cardiovascular events
10%

5.
Primary objectives

Secondary objectives

6.

(Objectives)

7.

8.
Health behavior
Health Index
Cardiovascular disease

Lifestyle changes
9.

(Research design)
(Experimental study)

10.

(Research methodology)

10.1

(Target population)

(Study population)

10.2
(Inclusion criteria)

BMI > 25 kg/m2

(Exclusion criteria)

10.3

(Observation and measurement)

1.

1.
2.
3.
4.

waist/height ratio

1.
2.
3.

pedometer

11.

(Data collection)

12.

(Data analysis)
(QD)
-

(Percentage)

SPSS

13.

(Ethical consideration)

14.

(Limitation)

15.
(Expected benefit and application)

16.
(Obstacles and strategies to solve)

17.
6

18.

. .2557

19.

(Administration and time schedule)

2557
..-..

. .

..

.-..

20.

(reference)

1.
4 . . 2551-2552
2. Mottilo S, et al. The metabolic syndrome and cardiovascular risk. J Am Coll
Cardiol 2010
3. Moleeregpoom W, et al. Costs of payment in Thai acute coronary syndrome
patients. J Med Assoc Thai 2007
4.
5.
2551
6.Dagenais GR et al. Prognostic impact of body weight and abdominal
obesity in women and men with cardiovascular disease. Am Heart J 2005
Jan; 149:54-60.
7.The NAVIGATOR Study Group. Effect of valsartan on the incidence of
diabetes and cardiovascular events. N Engl J Med 2010 Mar 14